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GENERAL SURGERY
In the diagnosis of acute pancreatitis (AP), serum 
amylase and more recently lipase are the commonly 
used laboratory tests available to clinicians in South 
Africa (SA). Although the international literature 
has shown serum amylase to be a less sensitive and 
specific test for AP than serum lipase,[1-6] serum amylase remains 
the most popular first-line investigation for suspected AP owing to 
the perception that the test is less expensive.
Key to the diagnosis of AP are abdominal pain consistent 
with AP, serum pancreatic enzyme elevation more than three 
times the upper limit of normal (ULN), and typical findings on 
cross-sectional imaging. The latter is usually contrast-enhanced 
computed tomography (CECT). The presence of any two is 
considered diagnostic.[7] Of the two non-clinical criteria for a 
diagnosis of AP, in terms of convenience and cost-containment 
it would be logical to favour the laboratory test ahead of the 
computed tomography (CT) scan, provided that reliance can be 
placed on the accuracy of serum lipase or amylase levels. Use of 
an inferior test may lead to a less accurate and timely diagnosis of 
AP or other conditions that may mimic it, as well as unnecessary 
reliance on other investigations to counteract the lack of sensitivity 
and specificity of the less accurate test.
The proposed merits of serum lipase over amylase were not 
analysed in the three SA publications on AP.[8-10] Establishing 
whether lipase is a better test in our population would provide local 
evidence that serum lipase should be used instead of amylase as a 
first-line test for suspected AP.
Objective
We aimed to investigate the relative performance of serum lipase 
and amylase at our institution, in terms of both specificity for AP 
and sensitivity for the diagnosis of AP at the proposed threshold 
of three times the ULN. The data were also analysed to determine 
whether dual testing of serum lipase and amylase had any benefit 
over serum lipase as a ‘stand-alone’ test.
Methods
From January 2010 to July 2012 at Tygerberg Academic Hospital, 
Cape Town, South Africa, data were collected prospectively on 
all patients presenting to the surgical admissions unit with acute 
generalised or upper abdominal pain and initial raised serum 
lipase and/or amylase values.
Inclusion criteria were acute generalised or upper abdominal 
pain of less than 5 days’ duration, with or without radiation to 
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the back, and a raised serum lipase and/
or amylase value. Patients with a history 
of chronic abdominal pain were also 
included if they had an acute exacerbation 
requiring emergency admission, provided 
the diagnosis was not chronic pancreatitis. 
Patients were excluded if they were under 
13 years of age or had a history of recent 
penetrating or blunt abdominal trauma or 
incomplete/inconclusive clinical records. 
Clinical, endoscopic, operative, laboratory 
and imaging data were reviewed to confirm 
the final diagnosis for each case. Data 
collected were age, gender, value of raised 
serum amylase and lipase, diagnosis and 
method of diagnosis.
AP was diagnosed if at least two of 
the three criteria of the revised Atlanta 
classification[7] were met. All patients 
who presented with pain and findings 
typical of AP on clinical examination, but 
a serum lipase and amylase elevation of 
less than three times the ULN, had CECT 
or laparotomy to confirm the diagnosis. 
CECT was also used to exclude other 
conditions presenting with enzyme 
elevations of more than three times the 
ULN if the clinical findings were atypical 
for AP.
In cases where one of the serum markers 
was raised above the ULN but not the 
other, the value of the other marker was 
included as well. Conduct of the study was 
approved by the Health Research Ethics 
Committee of the Faculty of Medicine and 
Health Sciences at Stellenbosch University 
(reference N08/01/008).
The data were entered into an electronic 
spreadsheet. Descriptive statistical analysis 
was performed and results were expressed 
as percentages, medians and ranges. Sensi-
tivity and specificity for both enzymes for 
the diagnosis of AP were calculated using 
the cut-off of three times the ULN.
The samples were analysed in the Tyger-
berg Hospital National Health Laboratory 
Service (NHLS) laboratory, which is acc-
redited by the South African National 
Accreditation System and participates in 
external quality control. The analytes were 
measured using a Siemens Advia 1800 
system. The normal range for serum lipase 
was 0 - 60 U/L and that for serum amylase 
28 - 110 U/L.
Results
During the study period, 760 patients 
presented with abdominal pain and a raised 
serum lipase and/or amylase value. Of 
these, 476 met the inclusion criteria and 
were included in the final analysis. The 
median age of these patients was 43 years 
(range 14 - 85), and 58% were male and 
42% female.
Of the 476 patients, 322 (68%) presented 
with abdominal conditions other than AP. 
There were 25 extrapancreatic diagnoses, the 
most common being gastritis/non-perforated 
peptic ulcer, perforated gastric or duodenal 
ulcer, intestinal obstruction, nonspecific 
abdominal pain, appendicitis and abdominal 
tuberculosis. In 154 patients, the final 
diagnosis was AP. The cause of the AP was 
ethanol abuse in 55% and gallstones in 23%. 
Causes of AP, with corresponding serum 
enzyme values, are summarised in Table 1.
Table 2 shows the distribution of pan-
creatic enzyme elevations above and below 
the cut-off level. Above three times the 
ULN, specificity for AP was similar, with 
lipase and amylase being 92% and 93% 
specific for AP, respectively. The most 
striking difference between the enzymes 
was in sensitivity for AP. Above the 
threshold level of three times the ULN, 
lipase displayed a superior sensitivity of 
91% for AP as opposed to 62% for amylase. 
At the cut-off level of three times the ULN, 
amylase as a single test would not have 
been diagnostic in 38% of cases of AP.
The sensitivity of amylase and lipase 
was calculated separately for ethanol- 
and gallstone-induced AP. Lipase was 
considerably more sensitive than amylase 
above the cut-off level for ethanol-induced 
AP (91% v. 52%), and was also more 
sensitive for gallstone-induced AP (97% v. 
80%) (Table 3).
The data were analysed to determine 
whether dual testing with both enzymes 
would lead to superior sensitivity for AP 






Ethanol 85 (55.2) 364 (70 - 2 964) 331.5 (41 - 1 972)
Gallstones 35 (22.7) 1114 (111 - 10 000) 874.5 (158 - 5 292)
Idiopathic 17 (11.0) 670.5 (30 - 2 843 487.5 (133 - 3 336)
Other 17 (11.0) 636 (59 - 5 135)  973 (147 - 2 182) 
Total 154 567 (30 - 10 000) 402 (41 - 5 292)
AP = acute pancreatitis.
Table 2. Specificity/sensitivity of lipase and amylase for AP at cut-off level
Acute pancreatitis, n Extrapancreatic conditions, n
Serum lipase
>3 × ULN 140 25
<3 × ULN 14 297
Serum lipase specificity for AP above threshold = 92%
Serum lipase sensitivity for AP above threshold = 91%
Serum amylase
>3 × ULN 96 24
<3 × ULN 58 298
Serum amylase specificity for AP above threshold = 93%
Serum amylase sensitivity for AP above threshold = 62%
AP = acute pancreatitis; ULN = upper limit of normal.
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over lipase alone. Table 4 sets out the 
distribution of AP cases that presented 
with an elevation in either lipase or 
amylase above three times the ULN. This 
shows that the sensitivity of dual testing 
above the threshold level is 93%, which 
is only marginally better than the 91% 
achieved by lipase as a single test.
Discussion
The presenting symptoms of AP (epi-
gastric or generalised abdominal pain, 
nausea and vomiting) are not exclusive 
to this disease but are shared by other 
abdominal emergencies, many requiring 
surgical intervention, such as peptic ulcer 
perforation and intestinal obstruction. 
The attending clinician can therefore not 
make a reliable diagnosis without the 
use of selected laboratory and imaging 
investigations. Serum lipase and amylase 
measurement are both commonly used in 
patients presenting with clinical features 
suspicious of AP, as a means of either 
confirming or excluding the diagnosis of 
AP. Use of these enzymes in this context 
is, however, subject to an understanding of 
their imperfections.
The first of these is the lack of specificity 
of these enzymes for AP, which relates 
to the ability to exclude AP in patients 
presenting with acute abdominal pain. It 
is well known that other intra-abdominal 
disorders, such as peptic ulcer perforation, 
mesenteric ischaemia and intestinal 
obstruction, may present with raised 
serum lipase/amylase values.[3,5,6,11] These 
elevations are usually mild (typically 
between one and two times the ULN). 
Although these extrapancreatic elevations 
may on occasion be very high, many 
authors have suggested that a cut-off level 
of three times the ULN be used, thereby 
increasing the specificity of the enzymes 
for AP.[1,3,11] These data show that, in line 
with other published data,[5-7] lipase and 
amylase are both very specific laboratory 
tests for the diagnosis of AP when the 
suggested cut-off level is used.
The more major imperfection is the 
lack of sensitivity of serum enzyme 
elevation to identify all those who have AP. 
Published experience has shown that AP 
is less likely to present with normal serum 
lipase than serum amylase values,[5,6,11-13] 
and this becomes more common with late 
presentations, when amylase levels tend to 
return to normal. Lipase has been shown 
to remain elevated longer than amylase 
after the onset of AP.[6] Our data show a 
considerable difference in sensitivity 
between the two enzymes when a cut-
off level is utilised to diagnose AP. Only 
62% of our patients with AP presented 
with a serum amylase elevation more than 
three times the ULN, implying that as a 
single test, amylase failed to satisfy the 
proposed diagnostic criteria in 38% (n=58) 
of AP patients. To avoid an unnecessary 
laparotomy, these patients require a CT scan 
to confirm the diagnosis. Lipase, on the 
other hand, had a sensitivity of 91% at the 
cut-off level, demonstrating its superiority 
in this regard, which should translate into 
significantly fewer diagnostic CT scans.
These findings should be interpreted 
within the context of the aetiology of AP in 
this study. In comparison with developed 
countries, where gallstones may play a 
larger causative role,[14] alcohol was by far 
the most common cause in this study. As 
ethanol-induced pancreatitis presents with 
lower serum enzyme elevations compared 
with gallstone pancreatitis, the sensitivity 
of these enzymes for AP will be negatively 
affected, especially when a cut-off level of 
three times the ULN is used.
The data showed that dual testing of 
lipase and amylase produced a sensitivity 
of 93% for AP at three times the ULN, 
which is an improvement of only 2% over 
lipase as a single test, a marginal gain 
achieved at double the cost. This finding 
is consistent with recent publications that 
concluded that testing of lipase alone is 
preferable to testing of amylase alone or 
both enzymes, and that this strategy may 
result in cost savings.[15,16] The NHLS cost 
is R38 for either test, while the typical cost 
at a laboratory servicing the private health 
sector is R60 each.[17,18]
Conclusion
We have shown that serum lipase is a more 
sensitive test and satisfies the diagnostic 
criteria for AP more readily than amylase. 
Table 4. Sensitivity of dual enzyme testing
AP Lipase and/or amylase, n Lipase alone, n
>3 × ULN 143 140
<3 × ULN 11 14
Dual testing sensitivity for AP above threshold = 93%
Serum lipase sensitivity for AP above threshold = 91%
AP = acute pancreatitis; ULN = upper limit of normal.
Table 3. Sensitivity of lipase and amylase for AP caused by ethanol and 
gallstones
Lipase, n Amylase, n
Ethanol-induced AP (N=85)
>3 × ULN 77 44
<3 × ULN 8 41
Serum lipase sensitivity for ethanol-induced AP above threshold = 91%
Serum amylase sensitivity for ethanol-induced AP above threshold = 52%
Gallstone-induced AP (N=35)
>3 × ULN 34 28
<3 × ULN 1 7
Serum lipase sensitivity for gallstone-induced AP above threshold = 97%
Serum amylase sensitivity for gallstone-induced AP above threshold = 80%
AP = acute pancreatitis; ULN = upper limit of normal.
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Dual testing in our setting adds little benefit compared with lipase 
as a ‘stand-alone’ test. The superior diagnostic performance of 
serum lipase has the potential to result in more efficient patient 
care and cost savings owing to less reliance on CECT to investigate 
patients presenting with acute abdominal pain. It is therefore 
recommended that serum lipase should supplant amylase as the 
first-line laboratory investigation for suspected AP.
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